Hepatic insulin gene therapy in insulin-dependent diabetes mellitus

American Journal of Transplantation

Volumn 3, Issue 10, 2003, Pages 1197-1203

  Nett, Philipp C ^a   Sollinger, Hans W ^a   Alam, Tausif ^a  

^a University of Wisconsin Health   (United States)

Author keywords

Gene therapy; Insulin; Insulin dependent diabetes mellitus; Liver

Indexed keywords

INSULIN; PREPROINSULIN;

AUTOIMMUNE DISEASE; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; GENE THERAPY; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LIVER CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SHORT SURVEY;

ANIMALS; DIABETES MELLITUS, TYPE 1; GENE THERAPY; GLUCOSE; HEPATOCYTES; HUMANS; INSULIN; ISLETS OF LANGERHANS; LIVER; MICE; MICE, INBRED NOD;

EID: 0141557850     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-6143.2003.00221.x     Document Type: Short Survey

References (108)

1. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lanet 2001; 358: 221-229.
2. Todd JA. Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci U S A 1995; 92: 8560-8565.
3. Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996; 85: 291-297.
4. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331: 1428-1436.
5. EURODIAB ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe. Lancet 2000; 355: 873-876.
6. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
7. Kenyon NS, Ranuncoli A, Masetti M, Chatzipetrou M, Ricordi C. Islet transplantation: present and future perspectives. Diabetes Metab Rev 1998; 14: 303-313.
8. Tyden G, Reinholt FP, Sundkvist G, Bolinder J. Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J Med 1996; 335: 860-863.
9. Bach JF. Immunotherapy of insulin-dependent diabetes mellitus. Curr Opin Immunol 2001; 13: 601-605.
10. Giannoukakis N, Rudert WA, Robbins PD, Trucco M. Targeting autoimmune diabetes with gene therapy. Diabetes 1999; 48: 2107-2121.
11. Docherty K. Gene therapy for diabetes mellitus. Clin Sci (Lond) 1997; 92: 321-330.
12. Soria B, Skoudy A, Martin F. From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus. Diabetologia 2001; 44:407-415.
13. Selden RF, Skoskiewicz MJ, Russell PS, Goodman HM. Regulation of insulin-gene expression. Implications for gene therapy. N Engl J Med 1987; 317: 1067-1076.
14. Newgard CB. Cellular engineering and gene therapy strategies for insulin replacement in diabetes. Diabetes 1994; 43: 341-350.
15. Halban PA, Kahn SE, Lernmark A, Rhodes CJ. Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must the standards be set? Diabetes 2001; 50: 2181-2191.
16. Kishimoto H, Sprent J. A defect in central tolerance in NOD mice. Nat Immunol 2001; 2: 1025-1031.
17. French MB, Allison J, Cram DS et al. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 1997; 46: 34-39.
18. Posselt AM, Barker CF, Friedman AL, Naji A. Prevention of autoimmune diabetes in the BB rat by intrathymic islet transplantation at birth. Science 1992; 256: 1321-1324.
19. Charlton B, Taylor-Edwards C, Tisch R, Fathman CG. Prevention of diabetes and insulitis by neonatal intrathymic islet administration in NOD mice. J Autoimmun 1994; 7: 549-560.
20. Tisch R, Wang B, Weaver DJ et al. Antigen-specific mediated suppression of beta cell autoimmunity by plasmid DNA vaccination. J Immunol 2001; 166: 2122-2132.
21. Coon B, An LL, Whitton JL, von Herrath MG. DNA immunization to prevent autoimmune diabetes. J Clin Invest 1999; 104: 189-194.
22. Piccirillo CA, Chang Y. Prud'homme GJTGF-beta1 somatic gene therapy prevents autoimmune disease in nonobese diabetic mice. J Immunol 1998; 161: 3950-3956.
23. Khachatryan A, Guerder S, Palluault F et al. Targeted expression of the neuropeptide calcitonin gene-related peptide to beta cells prevents diabetes in NOD mice. J Immunol 1997; 158: 1409-1416.
24. von Herrath MG, Efrat S, Oldstone MB, Horwitz MS. Expression of adenoviral E3 transgenes in beta cells prevents autoimmune diabetes. Proc Natl Acad Sci U S A 1997; 94: 9808-9813.
25. Ju Q, Edelstein D, Brendel MD et al. Transduction of non-dividing adult human pancreatic beta cells by an integrating lentiviral vector. Diabetologia 1998; 41: 736-739.
26. Yasuda H, Nagata M, Arisawa K et al. Local expression of immunoregulatory IL-12p4O gene prolonged syngeneic islet graft survival in diabetic NOD mice. J Clin Invest 1998; 102: 1807-1814.
27. Cameron MJ, Arreaza GA, Waldhauser L, Gauldie J, Delovitch TL. Immunotherapy of spontaneous type 1 diabetes in nonobese diabetic mice by systemic interleukin-4 treatment employing adenovirus vector-mediated gene transfer. Gene Ther 2000; 7: 1840-1846.
28. Kurrer MO, Pakala SV, Hanson HL, Katz JD. Beta cell apoptosis in T cell-mediated autoimmune diabetes. Proc Natl Acad Sci U S A 1997; 94: 213-218.
29. Savinov AY, Tcherepanov A, Green EA, Flavell RA, Chervonsky AV. Contribution of Fas to diabetes development. Proc Natl Acad Sci U S A 2003; 100: 628-632.
30. Liu Y, Rabinovitch A, Suarez-Pinzon W et al. Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic beta-cells from apoptosis. Hum Gene Ther 1996; 7: 1719-1726.
31. Honeyman MC, Harrison LC, Drummond B, Colman PG, Tait BD. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease. Mol Med 1995; 1: 576-582.
32. Bonifacio E, Bingley PJ, Shattock M et al. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990; 335: 147-149.
33. Barnett AH, Eff C, Leslie RD, Pyke DA. Diabetes in identical twinsA study of 200 pairs. Diabetologia 1981; 20: 87-93.
34. Madsen OD, Jensen J, Blume N et al. Pancreatic development and maturation of the islet B cell. Studies of pluripotent islet cultures. Eur J Biochem 1996; 242: 435-445.
35. Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE. A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes 1993; 42: 1715-1720.
36. Wang RN, Kloppel G, Bouwens L. Duct- to islet-cell differentiation and islet growth in the pancreas of duct-ligated adult rats. Diabetologia 1995; 38: 1405-1411.
37. Gu D, Sarvetnick N. Epithelial cell proliferation and islet neogenesis in IFN-g transgenic mice. Development 1993; 118: 33-46.
38. Rooman I, Schuit F, Bouwens L. Effect of vascular endothelial growth factor on growth and differentiation of pancreatic ductal epithelium. Lab Invest 1997; 76: 225-232.
39. Rafaeloff R, Pittenger GL, Barlow SW et al. Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters. J Clin Invest 1997; 99: 2100-2109.
40. Lefebvre VH, Otonkoski T, Ustinov J, Huotari MA, Pipeleers DG, Bouwens L. Culture of adult human islet preparations with hepatocyte growth factor and 804G matrix is mitogenic for duct cells but not for beta-cells. Diabetes 1998; 47: 134-137.
41. Watanabe T, Yonemura Y, Yonekura H et al. Pancreatic beta-cell replication and amelioration of surgical diabetes by Reg protein. Proc Natl Acad Sci U S A 1994; 91: 3589-3592.
42. Goldfine ID, German MS, Tseng HC et al. The endocrine secretion of human insulin and growth hormone by exocrine glands of the gastrointestinal tract. Nat Biotechnol 1997; 15: 1378-1382.
43. Welsh N. Gene therapy in diabetes mellitus: promises and pitfalls. Curr Opin Mol Ther 1999; 1: 464-470.
44. Hori Y, Rulifson IC, Tsai BC, Heit JJ, Cahoy JD, Kim SK. Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci U S A 2002; 99: 16105-16110.
45. Lechner A, Leech CA, Abraham EJ, Nolan AL, Habener JF. Nestin-positive progenitor cells derived from adult human pancreatic islets of Langerhans contain side population (SP) cells defined by expression of the ABCG2 (BCRP1) ATP-binding cassette transporter. Biochem Biophys Res Commun 2002; 293: 670-674.
46. Soria B, Roche E, Berna G, Leon-Quinto T, Reig JA, Martin F. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 2000; 49: 157-162.
47. Walther W, Stein U. Viral vectors for gene transfer: a review of their use in the treatment of human diseases. Drugs 2000; 60: 249-271.
48. Cheung AT, Dayanandan B, Lewis JT et al. Glucose-dependent insulin release from genetically engineered K cells. Science 2000; 290: 1959-1962.
49. Moore HP, Kelly RB. Secretory protein targeting in a pituitary cell line: differential transport of foreign secretory proteins to distinct secretory pathways. J Cell Biol 1985; 101 (5 Part 1): 1773-1781.
50. Hughes SD, Johnson JH, Quaade C, Newgard CB. Engineering of glucose-stimulated insulin secretion and biosynthesis in non-islet cells. Proc Natl Acad Sci U S A 1992; 89: 688-692.
51. Lipes MA, Cooper EM, Skelly R et al. Insulin-secreting non-islet cells are resistant to autoimmune destruction. Proc Natl Acad Sci U S A 1996; 93: 8595-8600.
52. Shifrin AL, Auricchio A, Yu QC, Wilson J, Raper SE. Adenoviral vector-mediated insulin gene transfer in the mouse pancreas corrects streptozotocin-induced hyperglycemia. Gene Ther 2001; 8: 1480-1489.
53. Jindal RM, Karanam M, Shah R. Prevention of diabetes in the NOD mouse by intra-muscular injection of recombinant adenoassociated virus containing the preproinsulin II gene. Int J Exp Diabetes Res 2001; 2: 129-138.
54. Riu E, Mas A, Ferre T et al. Counteraction of type 1 diabetic alterations by engineering skeletal muscle to produce insulin: insights from transgenic mice. Diabetes 2002; 51: 704-711.
55. Shaw JA, Delday MI, Hart AW, Docherty HM, Maltin CA, Docherty K. Secretion of bioactive human insulin following plasmid-mediated gene transfer to non-neuroendocrine cell lines, primary cultures and rat skeletal muscle in vivo. J Endocrinol 2002; 172: 653-672.
56. Groskreutz DJ, Sliwkowski MX, Gorman CM. Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin. J Biol Chem 1994; 269: 6241-6245.
57. Smeekens SP, Montag AG, Thomas G et al. Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3. Proc Natl Acad Sci U S A 1992; 89: 8822-8826.
58. Yanagita M, Hoshino H, Nakayama K, Takeuchi T. Processing of mutated proinsulin with tetrabasic cleavage sites to mature insulin reflects the expression of furin in nonendocrine cell lines. Endocrinology 1993; 133: 639-644.
59. Efrat S, Tal M, Lodish HF. The pancreatic beta-cell glucose sensor. Trends Biochem Sci 1994; 19: 535-538.
60. Alam T, Sollinger HW. Glucose-regulated insulin production in hepatocytes. Transplantation 2002; 74: 1781-1787.
61. Auricchio A, Gao GP, Yu QC et al. Constitutive and regulated expression of processed insulin following in vivo hepatic gene transfer. Gene Ther 2002; 9: 963-971.
62. Chen R, Meseck M, McEvoy RC, Woo SL. Glucose-stimulated and self-limiting insulin production by glucose 6-phosphatase promoter driven insulin expression in hepatoma cells. Gene Ther 2000; 7: 1802-1809.
63. Chen R, Doiron B, Kahn A. Glucose responsiveness of a reporter gene transduced into hepatocytic cells using a retroviral vector. FEBS Lett 1995; 365: 223-226.
64. Chen R, Meseck ML, Woo SL. Auto-regulated hepatic insulin gene expression in type 1 diabetic rats. Mol Ther 2001; 3: 584-590.
65. Dong H, Morral N, McEvoy R, Meseck M, Thung SN, Woo SL. Hepatic insulin expression improves glycemic control in type 1 diabetic rats. Diabetes Res Clin Pract 2001; 52: 153-163.
66. Dong H, Altomonte J, Morral N, Meseck M, Thung SN, Woo SL. Basal insulin gene expression significantly improves conventional insulin therapy in type 1 diabetic rats. Diabetes 2002; 51: 130-138.
67. Falqui L, Martinenghi S, Berra C et al. Human proinsulin production in primary rat hepatocytes after retroviral vector gene transfer. J Mol Med 1999; 77: 250-253.
68. Gros L, Montoliu L, Riu E, Lebrigand L, Bosch F. Regulated production of mature insulin by non-beta-cells. Hum Gene Ther 1997; 8: 2249-2259.
69. Kolodka TM, Finegold M, Moss L, Woo SL. Gene therapy for diabetes mellitus in rats by hepatic expression of insulin. Proc Natl Acad Sci U S A 1995; 92: 3293-3297.
70. Lee HC, Kim SJ, Kim KS, Shin HC, Yoon JW. Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature 2000; 408: 483-488.
71. Matsumoto T, Yamaguchi M, Kuzume M et al. Insulin gene transfer improves posthepatectomized status of diabetic rats. Transplant Proc 2000; 32: 2378-2379.
72. Mitanchez D, Chen R, Massias JF et al. Regulated expression of mature human insulin in the liver of transgenic mice. FEBS Lett 1998; 421: 285-289.
73. Muzzin P, Eisensmith RC, Copeland KC, Woo SL. Hepatic insulin gene expression as treatment for type 1 diabetes mellitus in rats. Mol Endocrinol 1997; 11: 833-837.
74. Short DK, Okada S, Yamauchi K, Pessin JE. Adenovirus-mediated transfer of a modified human proinsulin gene reverses hyperglycemia in diabetic mice. Am J Physiol 1998; 275 (5 Part 1): E748-E756.
75. Simpson AM, Tuch BE, Swan MA, Tu J, Marshall GM. Functional expression of the human insulin gene in a human hepatoma cell line (HEP G2). Gene Ther 1995; 2: 223-231.
76. Sugiyama A, Hattori S, Tanaka S et al. Defective adenoassociated viral-mediated transfection of insulin gene by direct injection into liver parenchyma decreases blood glucose of diabetic mice. Horm Metab Res 1997; 29: 599-603.
77. Thule PM, Liu JM. Regulated hepatic insulin gene therapy of STZ-diabetic rats. Gene Ther 2000; 7: 1744-1752.
78. Thule PM, Liu J, Phillips LS. Glucose regulated production of human insulin in rat hepatocytes. Gene Ther 2000; 7: 205-214.
79. Tuch BE, Szymanska B, Yao M et al. Function of a genetically modified human liver cell line that stores, processes and secretes insulin. Gene Ther 2003; 10: 490-503.
80. Wanke IE, Wong NC. Specific problems facing gene therapy for insulin-dependent diabetes mellitus: glucose-regulated insulin secretion from hepatocytes. Proc West Pharmacol Soc 1997; 40: 131-133.
81. Lu D, Tamemoto H, Shibata H, Saito I, Takeuchi T. Regulatable production of insulin from primary-cultured hepatocytesinsulin production is up-regulated by glucagon and cAMP and down-regulated by insulin. Gene Ther 1998; 5: 888-895.
82. Valera A, Fillat C, Costa C et al. Regulated expression of human insulin in the liver of transgenic mice corrects diabetic alterations. FASEB J 1994; 8: 440-447.
83. Nordlie RC, Foster JD, Lange AJ. Regulation of glucose production by the liver. Annu Rev Nutr 1999; 19: 379-406.
84. Burcelin R, Dolci W, Thorens B. Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice. Diabetes 2000; 49: 1643-1648.
85. Tabiin MT, Tuch BE, Bai L, Han XG, Simpson AM. Susceptibility of insulin-secreting hepatocytes to the toxicity of proinflammatory cytokines. J Autoimmun 2001; 17: 229-242.
86. Lewis PF, Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 1994; 68: 510-516.
87. Zhang B, Xia HQ, Cleghorn G, Gobe G, West M, Wei MQ. A highly efficient and consistent method for harvesting large Volumes of high-titre lentiviral vectors. Gene Ther 2001; 8: 1745-1751.
88. Kaleko M, Garcia JV, Miller AD. Persistent gene expression after retroviral gene transfer into liver cells in vivo. Hum Gene Ther 1991; 2: 27-32.
89. Rettinger SD, Kennedy SC, Wu X et al. Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc Natl Acad Sci U S A 1994; 91: 1460-1464.
90. Woods NB, Muessig A, Schmidt M et al. Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis. Blood 2003; 101: 1284-1289.
91. Robbins PD, Ghivizzani SC. Viral vectors for gene therapy. Pharmacol Ther 1998; 80: 35-47.
92. Nishikawa M, Huang L. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 2001; 12: 861-870.
93. Li S, Ma Z. Nonviral gene therapyCurr Gene Ther 2001; 1: 201-226.
94. Zhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 1999; 10: 1735-1737.
95. Herweijer H, Zhang G, Subbotin VM, Budker V, Williams P, Wolff JA. Time course of gene expression after plasmid DNA gene transfer to the liver. J Gene Med 2001; 3: 280-291.
96. Herweijer H, Wolff JA. Progress and prospects naked DNA gene transfer and therapy. Gene Ther 2003; 10: 453-458.
97. Mitanchez D, Doiron B, Chen R, Kahn A. Glucose-stimulated genes and prospects of gene therapy for type I diabetes. Endocr Rev 1997; 18: 520-540.
98. Vaulont S, Kahn A. Transcriptional control of metabolic regulation genes by carbohydrates. FASEB J 1994; 8: 28-35.
99. Jacoby DB, Zilz ND, Towle HC. Sequences within the 5′-flanking region of the S14 gene confer responsiveness to glucose in primary hepatocytes. J Biol Chem 1989; 264: 17623-17626.
100. Shih HM, Towle HC. Definition of the carbohydrate response element of the rat S14 gene. Evidence for a common factor required for carbohydrate regulation of hepatic genes. J Biol Chem 1992; 267: 13222-13228.
101. Meyer S, Hoppner W, Seitz HJ. Transcriptional and posttranscriptional effects of glucose on liver phosphoenolpyruvate-carboxykinase gene expression. Eur J Biochem 1991; 202: 985-991.
102. Doiron B, Cuif MH, Kahn A, Diaz-Guerra MJ. Respective roles of glucose, fructose, and insulin in the regulation of the liver-specific pyruvate kinase gene promoter. J Biol Chem 1994; 269: 10213-10216.
103. Streeper RS, Svitek CA, Chapman S, Greenbaum LE, Taub R, O'Brien RM. A multicomponent insulin response sequence mediates a strong repression of mouse glucose-6-phosphatase gene transcription by insulin. J Biol Chem 1997; 272: 11698-11701.
104. Robertson DG, Marino EM, Thule PM, Seneviratne CK, Murphy LJ. Insulin and glucocorticoids regulate IGFBP-1 expression via a common promoter region. Biochem Biophys Res Commun 1994; 200: 226-232.
105. Rivera VM, Wang X, Wardwell S et al. Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum. Science 2000; 287: 826-830.
106. Ferber S, Halkin A, Cohen H et al. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 2000; 6: 568-572.
107. Kojima H, Fujimiya M, Matsumura K et al. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med 2003; 9: 596-603.
108. Sander M, German MS. The beta cell transcription factors and development of the pancreas. J Mol Med 1997; 75: 327-340.